STEMI patients in the TRITON-TIMI @ ( Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction @ ) were randomized to prasugrel or clopidogrel on presentation if primary PCI was intended or later during secondary PCI .